Research Article
Association of Biomarker Level with Cardiovascular Events: Results of a 4-Year Follow-Up Study
Table 2
Level of biochemical parameters in groups with and without event.
| Variables | Total N = 223 | No outcome N = 188 (84.3%) | Composite end point N = 35 (15.7%) | MACE n = 15 | χ2 | level | χ2 | level |
| Cholesterol, mmol/L, median (Q25–Q75) | 5.3 (4.57–6.3) | 5.56 (4.68–6.33) | 5.66 (4.50–6.59) | 5.53 (4.37–7.08) | 0.59 | 0.56 | 0.09 | 0.93 | Glucose, mmol/L, median (Q25–Q75) | 5.4 (5.1–5.8) | 5.85 (5.10–5.80) | 6.32 (5.10–6.1) | 6.92 (5.20–6.30) | 1.56 | 0.21 | 0.88 | 0.34 | Endocan, pg/ml, median (Q25–Q75) | 733.2 (68.8–3432.8) | 718.6 (101.8–3432.8) | 957.0 (68.8–2150.9) | 1185.6 (355.1–2150.9) | 2.39 | 0.017 | 3.27 | ≤0.001 | CXCL16, pg/ml, median (Q25–Q75) | 324.8 (4–2673.0) | 310.0 (4–1685) | 432.3 (64–2673.0) | 774.2 (293.0–2673.0) | 2.62 | 0.009 | 3.45 | ≤0.001 | H-FABP, pg/ml, median (Q25–Q75) | 2346.8 (343.2–53447.7) | 2154.2 (422.4–53447.7) | 3245.6 (343.2–23509.9) | 5443.4 (1837.4–23509.9) | 2.87 | 0.004 | 3.10 | 0.002 |
|
|
χ2 and between the no-outcome group and outcome group with a composite endpoint; χ2 and between the no-outcome group and outcome group with a MACE. |